202 related articles for article (PubMed ID: 31347296)
1. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.
Qiao F; Wang C; Luo C; Wang Y; Shao B; Tan J; Hu P; Xu Z
Mol Genet Genomic Med; 2019 Sep; 7(9):e897. PubMed ID: 31347296
[TBL] [Abstract][Full Text] [Related]
2. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
3. Further validation of craniosynostosis as a part of phenotypic spectrum of BCL11B-related BAFopathy.
Pande S; Mascarenhas S; Venkatraman A; Bhat V; Narayanan DL; Siddiqui S; Bielas S; Girisha KM; Shukla A
Am J Med Genet A; 2023 Aug; 191(8):2175-2180. PubMed ID: 37337996
[TBL] [Abstract][Full Text] [Related]
4. A novel variant in BCL11B in an individual with neurodevelopmental delay: A case report.
Yu Y; Jia X; Yin H; Jiang H; Du Y; Yang F; Yang Z; Li H
Mol Genet Genomic Med; 2023 Apr; 11(4):e2132. PubMed ID: 36683525
[TBL] [Abstract][Full Text] [Related]
5. [A case report of BCL11B mutation induced neurodevelopmental disorder and literature review].
Yan S; Wei YS; Yang QY; Yang L; Zeng T; Tang XM; Zhao XD; An YF
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):223-227. PubMed ID: 32135595
[No Abstract] [Full Text] [Related]
6. Identification of two novel variants of the
Che F; Tie X; Lei H; Zhang X; Duan M; Zhang L; Yang Y
Front Mol Neurosci; 2022; 15():927357. PubMed ID: 36176959
[TBL] [Abstract][Full Text] [Related]
7. BCL11B-related disorder in two canadian children: Expanding the clinical phenotype.
Prasad M; Balci TB; Prasad C; Andrews JD; Lee R; Jurkiewicz MT; Napier MP; Colaiacovo S; Guillen Sacoto MJ; Karp N
Eur J Med Genet; 2020 Sep; 63(9):104007. PubMed ID: 32659295
[TBL] [Abstract][Full Text] [Related]
8. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
[TBL] [Abstract][Full Text] [Related]
9. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
Fahey L; Donohoe G; Broin PÓ; Morris DW
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
[TBL] [Abstract][Full Text] [Related]
10. Mutant
Yang S; Kang Q; Hou Y; Wang L; Li L; Liu S; Liao H; Cao Z; Yang L; Xiao Z
Front Pediatr; 2020; 8():544894. PubMed ID: 33194885
[No Abstract] [Full Text] [Related]
11. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
[TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
[TBL] [Abstract][Full Text] [Related]
14. De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders.
Dulovic-Mahlow M; Trinh J; Kandaswamy KK; Braathen GJ; Di Donato N; Rahikkala E; Beblo S; Werber M; Krajka V; Busk ØL; Baumann H; Al-Sannaa NA; Hinrichs F; Affan R; Navot N; Al Balwi MA; Oprea G; Holla ØL; Weiss MER; Jamra RA; Kahlert AK; Kishore S; Tveten K; Vos M; Rolfs A; Lohmann K
Am J Hum Genet; 2019 Jul; 105(1):213-220. PubMed ID: 31230721
[TBL] [Abstract][Full Text] [Related]
15. The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.
Grabarczyk P; Winkler P; Delin M; Sappa PK; Bekeschus S; Hildebrandt P; Przybylski GK; Völker U; Hammer E; Schmidt CA
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203643
[TBL] [Abstract][Full Text] [Related]
16. Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals.
Sabbagh Q; Haghshenas S; Piard J; Trouvé C; Amiel J; Attié-Bitach T; Balci T; Barat-Houari M; Belonis A; Boute O; Brightman DS; Bruel AL; Caraffi SG; Chatron N; Collet C; Dufour W; Edery P; Fong CT; Fusco C; Gatinois V; Gouy E; Guerrot AM; Heide S; Joshi A; Karp N; Keren B; Lesieur-Sebellin M; Levy J; Levy MA; Lozano C; Lyonnet S; Margot H; Marzin P; McConkey H; Michaud V; Nicolas G; Nizard M; Paulet A; Peluso F; Pernin V; Perrin L; Philippe C; Prasad C; Prasad M; Relator R; Rio M; Rondeau S; Ruault V; Ruiz-Pallares N; Sanchez E; Shears D; Siu VM; Sorlin A; Tedder M; Tharreau M; Mau-Them FT; van der Laan L; Van Gils J; Verloes A; Whalen S; Willems M; Yauy K; Zuntini R; Kerkhof J; Sadikovic B; Geneviève D
Genet Med; 2024 Jan; 26(1):101007. PubMed ID: 37860968
[TBL] [Abstract][Full Text] [Related]
17. MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
Mak CCY; Doherty D; Lin AE; Vegas N; Cho MT; Viot G; Dimartino C; Weisfeld-Adams JD; Lessel D; Joss S; Li C; Gonzaga-Jauregui C; Zarate YA; Ehmke N; Horn D; Troyer C; Kant SG; Lee Y; Ishak GE; Leung G; Barone Pritchard A; Yang S; Bend EG; Filippini F; Roadhouse C; Lebrun N; Mehaffey MG; Martin PM; Apple B; Millan F; Puk O; Hoffer MJV; Henderson LB; McGowan R; Wentzensen IM; Pei S; Zahir FR; Yu M; Gibson WT; Seman A; Steeves M; Murrell JR; Luettgen S; Francisco E; Strom TM; Amlie-Wolf L; Kaindl AM; Wilson WG; Halbach S; Basel-Salmon L; Lev-El N; Denecke J; Vissers LELM; Radtke K; Chelly J; Zackai E; Friedman JM; Bamshad MJ; Nickerson DA; ; Reid RR; Devriendt K; Chae JH; Stolerman E; McDougall C; Powis Z; Bienvenu T; Tan TY; Orenstein N; Dobyns WB; Shieh JT; Choi M; Waggoner D; Gripp KW; Parker MJ; Stoler J; Lyonnet S; Cormier-Daire V; Viskochil D; Hoffman TL; Amiel J; Chung BHY; Gordon CT
Brain; 2020 Jan; 143(1):55-68. PubMed ID: 31834374
[TBL] [Abstract][Full Text] [Related]
18. A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.
Goos JAC; Vogel WK; Mlcochova H; Millard CJ; Esfandiari E; Selman WH; Calpena E; Koelling N; Carpenter EL; Swagemakers SMA; van der Spek PJ; Filtz TM; Schwabe JWR; Iwaniec UT; Mathijssen IMJ; Leid M; Twigg SRF
Hum Mol Genet; 2019 Aug; 28(15):2501-2513. PubMed ID: 31067316
[TBL] [Abstract][Full Text] [Related]
19. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay.
Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM
Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196
[TBL] [Abstract][Full Text] [Related]
20. De novo variants in neurodevelopmental disorders-experiences from a tertiary care center.
Brunet T; Jech R; Brugger M; Kovacs R; Alhaddad B; Leszinski G; Riedhammer KM; Westphal DS; Mahle I; Mayerhanser K; Skorvanek M; Weber S; Graf E; Berutti R; Necpál J; Havránková P; Pavelekova P; Hempel M; Kotzaeridou U; Hoffmann GF; Leiz S; Makowski C; Roser T; Schroeder SA; Steinfeld R; Strobl-Wildemann G; Hoefele J; Borggraefe I; Distelmaier F; Strom TM; Winkelmann J; Meitinger T; Zech M; Wagner M
Clin Genet; 2021 Jul; 100(1):14-28. PubMed ID: 33619735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
